| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8317187 | Clinical Biochemistry | 2015 | 4 Pages |
Abstract
The results demonstrate that these novel, chemically synthesized SAP-Cs function as activators, stabilizers, and protectors of GCase, suggesting their utility in enzyme replacement therapy in patients with Gaucher's disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Azusa Yoneshige, Masanaga Muto, Takashi Watanabe, Hironobu Hojo, Junko Matsuda,